Short Interest in DarioHealth Corp. (NASDAQ:DRIO) Decreases By 64.9%

DarioHealth Corp. (NASDAQ:DRIO) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 60,781 shares, a decline of 64.9% from the November 30th total of 173,193 shares. Based on an average trading volume of 23,716 shares, the days-to-cover ratio is presently 2.6 days. Currently, 1.0% of the company’s shares are sold short. Currently, 1.0% of the company’s shares are sold short. Based on an average trading volume of 23,716 shares, the days-to-cover ratio is presently 2.6 days.

DarioHealth Trading Up 1.3%

DRIO traded up $0.13 on Friday, reaching $10.17. 2,566 shares of the company traded hands, compared to its average volume of 34,355. The company has a quick ratio of 4.02, a current ratio of 4.55 and a debt-to-equity ratio of 0.41. The company has a market cap of $68.75 million, a P/E ratio of -0.91 and a beta of 1.08. The firm has a fifty day simple moving average of $12.76 and a two-hundred day simple moving average of $12.33. DarioHealth has a one year low of $5.93 and a one year high of $31.00.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DRIO. Cowen restated a “hold” rating on shares of DarioHealth in a research note on Friday, November 14th. Stifel Nicolaus set a $16.00 price objective on DarioHealth in a research note on Friday, November 14th. Wall Street Zen upgraded shares of DarioHealth from a “sell” rating to a “hold” rating in a research report on Sunday, December 21st. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of DarioHealth in a report on Monday. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $32.00.

Hedge Funds Weigh In On DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. XTX Topco Ltd raised its holdings in shares of DarioHealth Corp. (NASDAQ:DRIO) by 229.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,511 shares of the company’s stock after acquiring an additional 43,513 shares during the quarter. XTX Topco Ltd owned approximately 0.14% of DarioHealth worth $42,000 as of its most recent filing with the SEC. Institutional investors own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.